ZA983626B - Pharmaceutical compositions against peptic ulcer - Google Patents

Pharmaceutical compositions against peptic ulcer

Info

Publication number
ZA983626B
ZA983626B ZA983626A ZA983626A ZA983626B ZA 983626 B ZA983626 B ZA 983626B ZA 983626 A ZA983626 A ZA 983626A ZA 983626 A ZA983626 A ZA 983626A ZA 983626 B ZA983626 B ZA 983626B
Authority
ZA
South Africa
Prior art keywords
peptic ulcer
pharmaceutical compositions
compositions against
against peptic
daltons
Prior art date
Application number
ZA983626A
Other languages
English (en)
Inventor
Janos Illes
Judit Matuz
Erzsebet Neszmelyi
Bela Stefko
Gaborne Forrai
Laszlo Szporny
Katalin Saghy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ZA983626B publication Critical patent/ZA983626B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
ZA983626A 1997-04-29 1998-04-29 Pharmaceutical compositions against peptic ulcer ZA983626B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Publications (1)

Publication Number Publication Date
ZA983626B true ZA983626B (en) 1998-11-05

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983626A ZA983626B (en) 1997-04-29 1998-04-29 Pharmaceutical compositions against peptic ulcer

Country Status (27)

Country Link
US (1) US6656921B1 (zh)
EP (1) EP1017403B1 (zh)
JP (1) JP2001522361A (zh)
KR (1) KR100572190B1 (zh)
CN (1) CN1126548C (zh)
AT (1) ATE320814T1 (zh)
BG (1) BG64458B1 (zh)
BR (1) BR9809354A (zh)
CA (1) CA2286756C (zh)
CZ (1) CZ297317B6 (zh)
DE (1) DE69833937T2 (zh)
DK (1) DK1017403T3 (zh)
EA (1) EA002134B1 (zh)
EE (1) EE04953B1 (zh)
ES (1) ES2259813T3 (zh)
HK (1) HK1025250A1 (zh)
HU (1) HU225991B1 (zh)
IL (1) IL132214A0 (zh)
NO (1) NO328313B1 (zh)
NZ (1) NZ500978A (zh)
PL (1) PL189526B1 (zh)
PT (1) PT1017403E (zh)
SK (1) SK284864B6 (zh)
TW (1) TW501927B (zh)
UA (1) UA62964C2 (zh)
WO (1) WO1998048815A1 (zh)
ZA (1) ZA983626B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
US8057294B2 (en) * 2005-09-09 2011-11-15 Wms Gaming Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP6095014B2 (ja) * 2012-03-01 2017-03-15 キユーピー株式会社 浮腫抑制用経口剤
US20160287627A1 (en) * 2013-11-22 2016-10-06 Kewpie Corporation Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
EP0259485A4 (en) * 1986-03-14 1988-07-29 Bio Technology General Corp HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
NO995229L (no) 1999-12-22
PT1017403E (pt) 2006-07-31
EP1017403A1 (en) 2000-07-12
EP1017403B1 (en) 2006-03-22
DE69833937T2 (de) 2007-06-06
BR9809354A (pt) 2000-07-04
EA002134B1 (ru) 2001-12-24
EA199900983A1 (ru) 2000-08-28
CZ382799A3 (cs) 2000-03-15
JP2001522361A (ja) 2001-11-13
WO1998048815A1 (en) 1998-11-05
CN1254285A (zh) 2000-05-24
HUP9700826A1 (hu) 1998-12-28
SK146899A3 (en) 2000-06-12
DK1017403T3 (da) 2006-07-31
PL336482A1 (en) 2000-06-19
CA2286756C (en) 2008-02-19
KR100572190B1 (ko) 2006-04-18
HU225991B1 (en) 2008-02-28
IL132214A0 (en) 2001-03-19
HK1025250A1 (en) 2000-11-10
NO328313B1 (no) 2010-01-25
BG64458B1 (bg) 2005-03-31
SK284864B6 (sk) 2006-01-05
US6656921B1 (en) 2003-12-02
ATE320814T1 (de) 2006-04-15
NZ500978A (en) 2001-05-25
ES2259813T3 (es) 2006-10-16
BG103822A (en) 2000-04-28
HU9700826D0 (en) 1997-06-30
EE04953B1 (et) 2008-02-15
UA62964C2 (en) 2004-01-15
CA2286756A1 (en) 1998-11-05
KR20010020413A (ko) 2001-03-15
DE69833937D1 (de) 2006-05-11
PL189526B1 (pl) 2005-08-31
NO995229D0 (no) 1999-10-26
CN1126548C (zh) 2003-11-05
TW501927B (en) 2002-09-11
EE9900470A (et) 2000-06-15
CZ297317B6 (cs) 2006-11-15

Similar Documents

Publication Publication Date Title
HU9700826D0 (en) Pharmaceutical compositions against peptic ulcer
NZ287335A (en) Copolymer-1 composition substantially free of species of copolymer -1 with a mw of from 4 kda to 8 kda, in particular 6.25 kda to 8.4 kda
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
HK1022089A1 (en) Use of low molecular weight amino alcohols in ophthalmic compositions
BG101131A (en) 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
EP0789553A4 (en) DEODORANT, ANTIMICROBIAL AND CONSERVATIVE COMPOSITIONS AND METHODS OF USE THEREOF
AU4310097A (en) Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
UA37263C2 (uk) Протруйник та спосіб протруювання насіння
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
TW362020B (en) Release-controlled implantable somatotropin composition
IL129385A (en) Composition of beta - glucosamine oligomers for treating fungal diseases in animals
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
EP0744176A3 (en) Methods for inhibiting bone loss
IL131478A0 (en) Methods for treatment of scar tissue
BG104914A (en) Paroxetine maleate
GB9505082D0 (en) Medicament
CA2171728A1 (en) Triaryl-ethylene derivatives for use in therapy
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
PL314799A1 (en) Application of dimeticone in treating constipations